FDA Advisors Recommend OTC Birth Control

Pharmacist holding contraceptives | Image by i viewfinder/Shutterstock

Food and Drug Administration advisors voted unanimously Wednesday in support of selling the birth-control pill Opill over the counter.

The advisors said the benefits would outweigh the risks.

The final vote was 17-0 for approval.

The FDA is expected to rule in the summer if it agrees with the recommendation.

The pill would be the first birth control pill sold without a prescription since oral contraceptives were approved more than 60 years ago.

Support our non-profit journalism